Dr. Nazia Chaudhary -Cancer research- therapy resistance – Best Researcher Award 

ACTREC,TMC - India

Author Profile 

ORCID

🧪 Early academic pursuits

Chaudhary s. nazia's academic journey began with an intense passion for microbiology, which led her to achieve a stellar 80% in her bachelor’s degree from sophia college, university of mumbai, in 2013. she further pursued a master’s degree in microbiology at st. xavier’s college, where she graduated with distinction, securing 73.5% in 2015. her academic foundation set the stage for a doctoral pursuit at the advanced centre for treatment, research, and education in cancer (actrec), where she completed her phd in march 2022. her research explored the intricate mechanisms that promote tumorigenesis and resistance to radio- and chemotherapy.

🧬 Professional endeavors

Nazia embarked on a remarkable career as a dst inspire faculty at actrec-tata memorial centre (tmc). her dedication to understanding cancer biology has been a cornerstone of her professional work. through rigorous experimentation and innovative approaches, she has consistently contributed to advancing research in oncology. her faculty position at actrec underscores her commitment to fostering new scientific breakthroughs and mentoring future researchers in the field.

🔬 Contributions and research focus

Nazia’s research revolves around understanding cancer mechanisms at the molecular level. her phd project provided groundbreaking insights into the pathways that promote tumorigenesis and resistance to treatment in the absence of plakophilin 3. her earlier work includes projects on thermophiles from ganeshpuri hot springs, Cancer research- therapy resistance mitochondrial function regulation, and industrially important thermophilic actinomycetes. her innovative studies highlight her ability to blend fundamental microbiological concepts with cutting-edge biomedical applications.

🏆 Accolades and recognition

Nazia’s groundbreaking research has been recognized through prestigious patents. she is a co-inventor of two patents focused on antibodies against lipocalin-2 and Cancer research- therapy resistance their therapeutic applications. these patents signify her impactful contributions to cancer treatment strategies and her recognition as a key innovator in her field.

🌍 Impact and influence

Nazia’s work has influenced the scientific community by providing deeper insights into tumor biology and therapeutic resistance. her contributions to understanding Cancer research- therapy resistance mitochondrial regulation and cancer pathways have added valuable knowledge to the field of molecular oncology. as a dst inspire faculty, she continues to inspire and guide young researchers, amplifying her influence in shaping the next generation of scientists.

🌟 Legacy and future contributions

With her focus on uncovering novel therapeutic targets and mechanisms in oncology, nazia aims to create a legacy of impactful research that bridges fundamental science and clinical applications. her continued efforts in cancer research promise to deliver innovative solutions that could transform patient care and improve outcomes for those affected by the disease. her dedication to mentorship ensures her knowledge and passion will resonate through the researchers she inspires.

Notable Publications 

  • Title: LCN2 promotes focal adhesion formation and invasion by stimulating Src activation
    Author(s): Bhagya Shree Choudhary; Nazia Chaudhary; Aditi Vijan; Dibita Mandal; Leena Pilankar; Shubham Gawand; Bushra K. Khan; Anusha Shivashankar; Rinki Doloi; Neha Joshi et al.
    Journal: Preprint
  • Title: EGFR-to-Src family tyrosine kinase switching in proliferating-DTP TNBC cells creates a hyperphosphorylation-dependent vulnerability to EGFR TKI
    Author(s): Nazia Chaudhary; Bhagya Shree Choudhary; Anusha Shivashankar; Subhakankha Manna; Khyati Ved; Shagufa Shaikh; Sonal Khanna; Jeetnet Barr; Jagruti Dani; Nandini Verma
    Journal: Preprint
  • Title: GPX4-VIM equates a proliferating DTP state in TNBC subtypes with converged vulnerabilities to autophagy and glutathione inhibition
    Author(s): Nazia Chaudhary; Bhagya Shree Choudhary; Sushmita Patra; Shivani Malvankar; Anusha Shivashankar; Eeshrita Jog; Vaishali V. Kailje; Sonal Khanna; Subhakankha Manna; Sarthak Sahoo et al.
    Journal: Preprint
  • Title: Lipocalin 2 inhibits actin glutathionylation to promote invasion and migration
    Author(s): Choudhary BS; Chaudhary N; Shah M; Dwivedi N; P K S; Das M; Dalal SN
    Journal: FEBS Letters
  • Title: The Role of Lipocalin 2 (LCN2) in Regulating Ferroptosis and Therapy Resistance
    Author(s): Rinki Doloi; Nazia Chaudhary; Sorab N. Dalal
    Journal: National Research Scholars' Meet 2021 - Abstracts

Dr. Haifeng Wu – Medicinal chemistry – Best Researcher Award

Dr. Haifeng Wu - Medicinal chemistry - Best Researcher Award

Institute of Medicinal Plant Development, Chinese Academy of Medicinal Sciences & Peking Union Medical College - China 

Author Profile 

SCOPUS

Early academic pursuits 🎓

Dr. Haifeng Wu's academic journey began with a bachelor's degree in biochemical engineering from beijing university of chemical engineering in 2001. driven by a passion for plant biology and natural sciences, he pursued further studies at the northwest institute of plateau biology, chinese academy of sciences, where he earned his m.s. in botany in 2006. his curiosity and dedication to understanding ecological systems led him to complete his ph.d. in ecology from the same institute in 2009. this strong academic foundation set the stage for his distinguished career in medicinal plant research.

Professional endeavors 🏢

Dr. Wu is currently affiliated with the institute of medicinal plant development at the chinese academy of medicinal sciences & peking union medical college in beijing. in this role, he specializes in molecular modeling, chromatographical analysis, isolation, and modification of natural products. his expertise in biochemistry and plant biology has been instrumental in advancing research on medicinal plants and natural compounds. dr. wu’s work at this prestigious institution reflects his commitment to bridging traditional knowledge with modern scientific approaches to drug discovery.

Contributions and research focus 🔬

Throughout his career, dr. wu has made significant contributions to the fields of medicinal plant development and natural product chemistry. his research primarily focuses on molecular modeling, allowing for precise identification and modification of bioactive compounds in plants. he has developed cutting-edge techniques for Medicinal chemistry chromatographical analysis and isolation, contributing to the discovery of novel natural products with potential therapeutic applications. dr. wu’s work is pivotal in the search for new drugs derived from medicinal plants, targeting various diseases and health conditions.

Accolades and recognition 🏅

Dr. Wu’s achievements have not gone unnoticed in the scientific community. his innovative research and contributions to medicinal plant development have earned Medicinal chemistry him recognition and accolades, both within china and internationally. while specific awards are not listed, his role at one of the leading research institutions in china underscores his expertise and the respect he commands in his field.

Impact and influence 🌍

Dr. Wu’s research has a profound impact on both the scientific community and the pharmaceutical industry. his work on the molecular modeling and modification of natural products is crucial for the development of new, effective treatments. by isolating and understanding plant-based compounds, dr. wu is helping to unlock the medicinal potential of nature, influencing future research and contributing to global health advancements. his work supports sustainable medicinal plant use and Medicinal chemistry conservation, making it environmentally and socially relevant.

Legacy and future contributions 🔮

As a researcher deeply rooted in the exploration of natural products and medicinal plants, dr. wu’s legacy will be one of innovation and dedication to improving human health. his future contributions are expected to further enhance the understanding and utilization of plant-based compounds in modern medicine. dr. wu’s pioneering work will continue to inspire researchers and contribute to the discovery of novel therapeutic agents, ensuring his place as a key figure in the field of medicinal plant development.

Notable Publications

  • Title: UV light treatment (278 nm) for detoxification of aflatoxins and application in edible and medicinal herb coix seed
    Authors: Zou, L., Sun, Z., Li, Q., Ma, G., Xu, X.
    Journal: International Journal of Food Science and Technology, 2024, 59(6), pp. 3723–3734
  • Title: Asiaticoside exerts neuroprotection through targeting NLRP3 inflammasome activation
    Authors: He, Z., Hu, Y., Zhang, Y., Wu, H., Hu, W.
    Journal: Phytomedicine, 2024, 127, 155494
  • Title: Identifying potential Q-markers for quality evaluation of Zhenyuan capsule by integrating chemical analysis, network pharmacology, molecular docking, and molecular dynamics simulations
    Authors: Zhao, Z., Yang, Q., Ma, Y., Wu, H., Liu, X.
    Journal: Natural Product Research, 2024
  • Title: Phenolic constituents with antibacterial activity from Eleutherine bulbosa
    Authors: Sun, Z., Li, Q., Zhang, J., Xu, X., Ma, G.
    Journal: Fitoterapia, 2024, 172, 105787
  • Title: Molecular interaction of soybean protein and piperine by computational docking analyses
    Authors: Zhang, C., Niu, Z., He, Z., Gu, F., Hu, W.
    Journal: Food Hydrocolloids, 2024, 146, 109249